Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectra (unres) Regulatory News (SPSY)

Share Price Information for Spectra (unres) (SPSY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 221.00
Bid: 216.00
Ask: 226.00
Change: 0.00 (0.00%)
Spread: 10.00 (4.63%)
Open: 221.00
High: 221.00
Low: 221.00
Prev. Close: 221.00
SPSY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Director

9 Feb 2021 14:11

RNS Number : 5060O
Spectra Systems Corporation
09 February 2021
 

Spectra Systems Corporation

Appointment of Director

Spectra Systems Corporation, a leader in machine-readable high speed banknote authentication, brand protection technologies, and gaming security software, is pleased to announce that it has appointed Jeremy Edward Fry (aged 56) to the Board as a Non-Executive director with immediate effect.

Following a successful executive international career with large scale enterprises, Jeremy, who is based in the UK, established his own consultancy business in 2005. He is experienced in finance and operations and in particular intellectual property. Since forming the consultancy business Jeremy has worked across a broad spectrum of businesses clients advising start-ups to public listed enterprises.

Over the past 15 years Jeremy has assumed numerous roles including Executive Chairman, Non-Executive Chairman, Non-Executive Director, CEO and COO leading and supporting a number of successful investor acquisitions and exits. More recently, Jeremy has been focused on advisory and non-executive initiatives including his appointment to the boards of Blackspace Security Limited and Sentrybay Limited, leading cyber-security companies working in financial services and regulated markets, where he is chair of the audit committee. Through 2019 and 2020 much of his time was spent working on a very significant restructuring of an industrials company involving negotiations with lenders and shareholders, addressing balance sheet and operational challenges.

Jeremy, a Chartered Marketeer, holds a degree in Biochemistry and Molecular Biology from Cardiff Metropolitan University (formerly Llandaff Technical College), a postgraduate diploma in Marketing from the Chartered Institute of Marketing via Cardiff Business School and an Executive MBA from the University of Reading.

A list of Jeremy Fry's current directorships together with those held within the last five years is set out below:

Current directorships:

Sentrybay Limited

Blackspace Security Limited

J4 Asset Management Limited

 

Previous directorships during the last five years:

Accord Bidco Limited

Ainscough Crane Hire Limited

Apollo Technology Partners Limited

Autologic Diagnostics Limited

LGDA Limited

 

Jeremy Fry has confirmed that there is no further information to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules.

 

Dr. Nabil Lawandy, Chief Executive Officer, stated: "We are elated that Jeremy has joined the Spectra Systems Board of Directors as he brings a deep experience base in technology driven companies from pharmaceuticals to cybersecurity. Jeremy also has hands on operational experience as well as an understanding of financial markets and transactions which includes private equity, acquisitions and public markets."

 

Enquiries:

 

Spectra Systems Corporation

Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700

 

WH Ireland Limited

Chris Fielding, Managing Director, Corporate Finance Tel: +44 (0) 20 7220 1650 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUBUPUPGGCB
Date   Source Headline
3rd Apr 20247:00 amRNSCertified Circular Polymer Banknote Substrate
27th Mar 20247:00 amRNSAudited results for 12 months ended 31 Dec 2023
13th Mar 20243:07 pmRNSNotice of Results
11th Jan 20247:00 amRNSExercise of Options and Director/PDMR Shareholding
28th Dec 20237:00 amRNSExercise of Options
21st Dec 202312:15 pmRNSCompletion of Acquisition
15th Dec 20234:35 pmRNSExercise of Options and transfer of shares
4th Dec 20237:00 amRNSAcquisition of Cartor Holdings Limited
6th Nov 20234:43 pmRNSTR-1
12th Oct 20237:00 amRNSLargest Central Bank Consumables Order
25th Sep 20237:00 amRNSInterim Results for Six Months Ended 30 June 2023
6th Sep 20237:00 amRNSResults for the 6 months ended 30 June 2023
7th Jul 20236:01 pmRNSRemoval of Regulation S restrictions from shares
26th Jun 20233:22 pmRNSAnnual General Meeting Lack of Quorum
14th Jun 20237:00 amRNSUpdate on Development Contracts
30th May 20237:00 amRNSAppointment of Chief Financial Officer
25th Apr 20237:00 amRNSAdditional Sensor Services Contract Amendment
24th Apr 20237:00 amRNSResignation of Chief Financial Officer
19th Apr 20237:05 amRNSRemoval of Reg S restrictions from common stock
6th Apr 20237:00 amRNSExercise of Options
31st Mar 20235:14 pmRNSRemoval of Reg S restrictions from shares
21st Mar 202311:44 amRNSDividend Record Date
20th Mar 20237:00 amRNSAudited results for year ended 31 December 2022
16th Mar 20234:35 pmRNSExercise of Options
13th Mar 20237:00 amRNSNotice of Results
6th Mar 202310:39 amRNSRemoval of Reg S restrictions from common stock
11th Oct 20226:12 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSContract Amendment to a Central Bank
21st Sep 20227:00 amRNSExercise of Options
12th Sep 20227:05 amRNSAppointment of Non-Executive Director
12th Sep 20227:00 amRNSInterim Results for Six Months Ended 30 June 2022
16th Aug 20227:00 amRNSFirst Banknote Disinfection System Sold
15th Aug 20227:00 amRNSNew Central Bank Contract Amendment
28th Jul 20227:00 amRNSShare Buy-Back
1st Jul 20222:31 pmRNSShare Buy-Back
28th Jun 20227:00 amRNSShare Buy-Back
15th Jun 20227:00 amRNSAdditional Central Bank Development Revenues
14th Jun 20227:00 amRNSAppointment of Chief Financial Officer
13th Jun 20227:00 amRNSUpdate regarding Solaris
13th Jun 20227:00 amRNSAnnual General Meeting Update
25th May 20227:00 amRNSExercise of Options and Director/PDMR Shareholding
20th May 20228:44 amRNSRemoval of Regulation S restrictions from shares
20th May 20228:41 amRNSResignation of Chief Financial Officer
3rd May 20227:00 amRNSPosting of Annual Report & Notice of AGM
6th Apr 20221:36 pmRNSRemoval of Reg S restrictions from common stock
28th Mar 20227:00 amRNSGrant of Share Options
21st Mar 20227:00 amRNSResults twelve months ended 31 December 2021
24th Feb 20227:00 amRNSSpectra Introduces Covert Polymer Substrate
24th Jan 20227:00 amRNSNew contract awards
21st Jan 20227:00 amRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.